Order Article Reprints

Collina F, La Sala L, Liotti F, Prevete N, La Mantia E, Chiofalo MG, Aquino G, Arenare L, Cantile M, Liguori G, et al. AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer. Cancers. 2019; 11(6):785. https://doi.org/10.3390/cancers11060785

Collina, Francesca, Lucia La Sala, Federica Liotti, Nella Prevete, Elvira La Mantia, Maria Grazia Chiofalo, Gabriella Aquino, Laura Arenare, Monica Cantile, Giuseppina Liguori, and et al. 2019. "AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer" Cancers 11, no. 6: 785. https://doi.org/10.3390/cancers11060785

Collina, F., La Sala, L., Liotti, F., Prevete, N., La Mantia, E., Chiofalo, M. G., Aquino, G., Arenare, L., Cantile, M., Liguori, G., Di Gennaro, F., Pezzullo, L., Losito, N. S., Vecchio, G., Botti, G., Melillo, R. M., & Franco, R. (2019). AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer. Cancers, 11(6), 785. https://doi.org/10.3390/cancers11060785